Trial Identifier: | D2287R00187 |
Sponsor: | AstraZeneca |
Start Date: | June 2024 |
Primary Completion Date: | July 2027 |
Study Completion Date: | July 2027 |
Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | Beijing, China |
China | Changsha, China |
China | Chengdu, China |
China | Guangzhou, China |
China | Hefei, China |
China | Nanjing, China |
China | Nanning, China |
China | Shanghai, China |
China | Shenyang, China |
China | Wuhan, China |
China | Xuzhou, China |
China | Zhengzhou, China |